Methods special issue: RNA-targeting technologies.
Methods special issue: RNA-targeting technologies.
复制标题
方法特刊:RNA 靶向技术。
DOI:
10.1016/j.ymeth.2023.02.006
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
O'Connell,MitchellR
中科院分区:
文献类型:
--
作者:
Knott,GavinJ;Lapinaite,Audrone;O'Connell,MitchellR
RNA is the centerpiece for all biology. The rising prominence of RNA as a therapeutic and therapeutic target has driven researchers to ask increasingly challenging questions about the function of RNA from sequence to modifications, localization, shape, and dynamics. Answering these questions requires tools to specifically recognize RNA and investigate its function both in vitro and in vivo. While there is a temptation to embrace a single platform technology that allows for robust RNA-targeting, the transience, structural complexity, and dynamics of RNA make it inherently difficult to target. To realize the potential of RNA and study the breadth of its functional complexity requires a rich toolbox of sophisticated solutions that are validated and tailored to a target of interest. The goal behind this Methods Special Issue is to provide a snapshot of some members of the current toolkit for precisely targeting RNA. From small molecules to larger programmable macromolecular complexes, this compilation of articles describes an emerging field of diverse tools that are significant steps towards tackling the complexity of RNA and its applications.RNA is a highly dynamic and adaptable molecule that can assume a variety of complex and distinct conformations, depending on its cellular localization, interaction partners, and metabolic cell state. This ability to change its shape allows RNA to perform a wide range of essential functions in cells. The structured nature of some classes of RNA makes it an attractive therapeutic target, especially if it encodes or regulates an undruggable protein. One of the approaches to target RNA relays on selective interactions between the RNA and small organic molecules, known as ligands. Understanding the on-and off-target RNA-ligand interactions is critical for the development of new drugs and therapies. Sexton et al.[1] address the need to detect transcriptome-wide RNA-ligand interactions in vitro and in physiologically relevant conditions by developing the Photoaffinity Evaluation of RNA Ligation-Sequencing (PEARL-seq) approach. This approach is based on crosslinking the ligand of interest (that has a photoreactive group attached) to the proximal RNA molecules via UV-irradiation. High throughput sequencing then allows single nucleotide resolution detection of the cross-linked site, that is, the RNA-ligand interaction site. Knowledge of when, where, and how ligands interact with structured RNA paves the way to identifying novel druggable sites in RNA.
影响因子:
4.8
作者:
A. N. Sexton;Lee E. Vandivier;Jennifer C Petter;Herschel Mukherjee;J. Craig Blain
通讯作者:
J. Craig Blain
影响因子:
4.8
作者:
Lukas Rösner;Dennis Reichert;Kristina Rau;N. Muthmann;A. Rentmeister
通讯作者:
A. Rentmeister
影响因子:
4.8
作者:
Burris, Brandon Joseph Davis;Vargas, Adrian Moises Molina;Park, Brandon J.;O'Connell, Mitchell R.
通讯作者:
O'Connell, Mitchell R.